Targeted liposomal nano-therapy combining anthocyanin and cisplatin reduces Ehrlich ascites carcinoma burden
Cis Ls and Ant Ls delivery strategy mitigates liver and kidney damage while enhancing anticancer efficacy against EAC.
Authors
- Sara H. El-Shafiey (ORCID: https://orcid.org/0000-0002-2510-4063)
- Nemany A. N. Hanafy (ORCID: https://orcid.org/0000-0001-5861-6973)
- Rasha Hamed Al‐Serwi (ORCID: https://orcid.org/0000-0002-2121-9269)
- Ramadan A. Ali (ORCID: https://orcid.org/0000-0003-1507-1517)
- Ahmed Badawy (ORCID: https://orcid.org/0000-0002-4966-3839)
- Mai G. Awad
- Mohammed A. El‐Magd (ORCID: https://orcid.org/0000-0002-3314-9202)
- Dalia Demerdash Abd El Monem Hafez (ORCID: https://orcid.org/0000-0002-0927-6674)
Institutions
- Princess Nourah bint Abdulrahman University (SA)
- Ain Shams University (EG)
- Northern Border University (SA)
- Kafrelsheikh University (EG)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-10-03
- DOI
- https://doi.org/10.3389/fphar.2025.1659575
- Citations
- 1
- Primary Topic
- Curcumin's Biomedical Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.59